Literature DB >> 19571461

Biochemical evidence of atherosclerosis progression mediated by increased oxidative stress in apolipoprotein E-deficient spontaneously hyperlipidemic mice exposed to chronic cigarette smoke.

Masaru Kunitomo1, Yu Yamaguchi, Satomi Kagota, Noriko Yoshikawa, Kazuki Nakamura, Kazumasa Shinozuka.   

Abstract

Cigarette smoking is a major risk factor for cardiovascular disease. The induction of oxidative stress by smoking plays a key role in the progression of atherosclerosis. However, the underlying mechanisms are not fully understood. In the present study, we investigated whether long-term smoking can accelerate the progression of atherosclerosis and whether oxidative stress is implicated in its pathogenesis. Apolipoprotein E-deficient spontaneously hyperlipidemic mice, a model of atherosclerosis, were exposed to the gas-phase of smoke, from which tar and nicotine had been removed, for 15 min a day, 6 days a week, for 16 weeks. Exposure to cigarette smoke significantly increased the serum levels of oxidative stress markers such as thiobarbituric acid-reactive substances, oxidatively modified low-density lipoproteins, and 3-nitrotyrosine, but it did not affect serum cholesterol and triglyceride levels. Exposure to smoke also accelerated the accumulation of total cholesterol levels in the aorta that was accompanied by an increase in 3-nitrotyrosine levels of the atherosclerotic mice. These changes in the serum and aorta that progressed with exposure to smoke were prevented by vitamin E administration. Our data suggest that chronic cigarette smoking promotes and aggravates atherosclerosis and that the antioxidant vitamin E exerts an anti-atherogenic effect via reduction of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571461     DOI: 10.1254/jphs.09100fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  14 in total

1.  Attenuation of the cardiac inflammatory changes and lipid anomalies by (-)-epigallocatechin-gallate in cigarette smoke-exposed rats.

Authors:  A Gokulakrisnan; B Jayachandran Dare; C Thirunavukkarasu
Journal:  Mol Cell Biochem       Date:  2011-06-03       Impact factor: 3.396

2.  Impact of smoking status on cardiovascular outcomes following percutaneous coronary intervention.

Authors:  Burhan Mohamedali; Adhir Shroff
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

3.  Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice.

Authors:  M A Hassan Talukder; Wesley M Johnson; Saradhadevi Varadharaj; Jiarui Lian; Patrick N Kearns; Mohamed A El-Mahdy; Xiaoping Liu; Jay L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

4.  Quit smoking to outsmart atherogenesis: Molecular mechanisms underlying clinical evidence.

Authors:  Jessica Gambardella; Celestino Sardu; Cosimo Sacra; Carmine Del Giudice; Gaetano Santulli
Journal:  Atherosclerosis       Date:  2016-12-16       Impact factor: 5.162

5.  Post-diagnosis smoking and risk of cardiovascular, cancer, and all-cause mortality in survivors of 10 adult cancers: a prospective cohort study.

Authors:  Yafeng Wang; Huan Tao; Raheem J Paxton; Junfeng Wang; Sumaira Mubarik; Yongqian Jia; Wei Wang; Chuanhua Yu
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

6.  Association of cardiac and vascular changes with ambient PM2.5 in diabetic individuals.

Authors:  Alexandra Schneider; Lucas M Neas; Don W Graff; Margaret C Herbst; Wayne E Cascio; Mike T Schmitt; John B Buse; Annette Peters; Robert B Devlin
Journal:  Part Fibre Toxicol       Date:  2010-06-02       Impact factor: 9.400

7.  Smoking, COPD, and 3-nitrotyrosine levels of plasma proteins.

Authors:  Hongjun Jin; Bobbie-Jo Webb-Robertson; Elena S Peterson; Ruimin Tan; Diana J Bigelow; Mary Beth Scholand; John R Hoidal; Joel G Pounds; Richard C Zangar
Journal:  Environ Health Perspect       Date:  2011-06-06       Impact factor: 9.031

Review 8.  Immunity, atherosclerosis and cardiovascular disease.

Authors:  Johan Frostegård
Journal:  BMC Med       Date:  2013-05-01       Impact factor: 8.775

Review 9.  Immune mechanisms in atherosclerosis, especially in diabetes type 2.

Authors:  Johan Frostegård
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-29       Impact factor: 5.555

10.  A simple and rapid method for standard preparation of gas phase extract of cigarette smoke.

Authors:  Tsunehito Higashi; Yosuke Mai; Yoichi Noya; Takahiro Horinouchi; Koji Terada; Akimasa Hoshi; Prabha Nepal; Takuya Harada; Mika Horiguchi; Chizuru Hatate; Yuji Kuge; Soichi Miwa
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.